Curaleaf Holdings, Inc. cash flow statement CURLF

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Curaleaf Holdings, Inc. generated $21.1 million of cash from operations. It spent $17.1 million on capital expenditures. That left free cash flow of $4.0 million. The company returned $1.0 million in share buybacks to shareholders.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026 YTD
Jun 30, 2026
Operating
Depreciation and amortization
—
52
49
Stock-based compensation
—
14
20
Operating cash flow
—
21
50
Investing
Capital expenditures
—
17
33
Investing cash flow
—
-19
-34
Financing
Stock buybacks
—
1
1
Financing cash flow
—
-4
-11
Change in cash
Free cash flow
—
4
17
Per share
Free cash flow per share
—
0.02
0.06
Shareholder returns
Returned to shareholders
—
1
1
Share of free cash flow
—
24.80%
5.77%
Ratios
Free cash flow margin
—
1.14%
5.10%
Capital expenditures to revenue
—
4.84%
9.68%
Stock-based compensation to revenue
—
3.98%
5.92%
Cash conversion
—
—
4.02x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CURLF (OTC)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Stamford, CT
SEC filer status
Large accelerated filer
SEC CIK
1756770

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.